GeneDx Holdings Corp.
WGS
$85.74
-$5.87-6.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 67.74% | 121.10% | 80.34% | 37.56% | 66.82% |
| Total Depreciation and Amortization | 8.19% | 1,020.55% | -31.63% | -49.50% | -39.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.70% | -352.54% | -47.17% | 425.32% | 224.74% |
| Change in Net Operating Assets | 143.62% | 7.21% | 60.85% | 64.69% | -49.62% |
| Cash from Operations | 162.04% | 89.34% | 89.34% | 91.58% | 70.46% |
| Capital Expenditure | -1,283.52% | -28.37% | -476.79% | 51.05% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -354.98% | 196.05% | 73.93% | -2,135,000.00% | 378.35% |
| Cash from Investing | -1,216.01% | 89.33% | 71.41% | -101.41% | 282.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -97.19% | -4.30% | 22.39% | -201.71% | 84.84% |
| Issuance of Common Stock | 60,854.17% | 171,221.05% | -- | -98.19% | -99.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,231.96% | -34.14% | 1,633.26% | -105.29% | -100.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 190.53% | 120.67% | 102.62% | 51.91% | -120.89% |